86 related articles for article (PubMed ID: 11732400)
21. Mysterious metformin.
Chong CR; Chabner BA
Oncologist; 2009 Dec; 14(12):1178-81. PubMed ID: 20007645
[No Abstract] [Full Text] [Related]
22. [Thyroid dysfunction in patients with type 2 diabetes mellitus].
Tereshchenko IV; Suslina AA
Ter Arkh; 2014; 86(8):119-23. PubMed ID: 25306758
[TBL] [Abstract][Full Text] [Related]
23. [Oral diabetes treatment. Which substance is indicated at which time?].
Hamann A; Morcos M; Nawroth P
Internist (Berl); 2004 Dec; 45(12):1356-63. PubMed ID: 15536516
[TBL] [Abstract][Full Text] [Related]
24. Metformin as firstline treatment for type 2 diabetes: are we sure?
Boussageon R; Gueyffier F; Cornu C
BMJ; 2016 Jan; 352():h6748. PubMed ID: 26747716
[TBL] [Abstract][Full Text] [Related]
25. [Metformin is commonly used in patients with renal impairment].
Alscher MD
Dtsch Med Wochenschr; 2015 Nov; 140(22):1656. PubMed ID: 26536639
[No Abstract] [Full Text] [Related]
26. [Give them a pill?].
Beck-Nielsen H
Ugeskr Laeger; 2000 Jun; 162(23):3304. PubMed ID: 10895594
[No Abstract] [Full Text] [Related]
27. The proliferation of irrational metformin fixed-dose combinations in India.
Evans V; Pollock AM
Lancet Diabetes Endocrinol; 2015 Feb; 3(2):98-100. PubMed ID: 25618292
[No Abstract] [Full Text] [Related]
28. Treatment options following metformin in primary prevention populations with type 2 diabetes: which is the right road to take?
Koufakis T; Papanas N; Zebekakis P; Kotsa K
Expert Rev Clin Pharmacol; 2021 Oct; 14(10):1189-1192. PubMed ID: 34120551
[No Abstract] [Full Text] [Related]
29. Oral pharmacologic treatment of type 2 diabetes mellitus.
Richard T; Brohee D; Van Meerhaeghe A; Vanhaeverbeek M
Ann Intern Med; 2012 Jul; 157(1):76; author reply 76-7. PubMed ID: 22751769
[No Abstract] [Full Text] [Related]
30. Oral pharmacologic treatment of type 2 diabetes mellitus.
Rodbard HW; Jellinger PS
Ann Intern Med; 2012 Jul; 157(1):75-6; author reply 76-7. PubMed ID: 22751768
[No Abstract] [Full Text] [Related]
31. Oral pharmacologic treatment of type 2 diabetes mellitus.
Moskowitz RS
Ann Intern Med; 2012 Jul; 157(1):75; author reply 76-7. PubMed ID: 22751767
[No Abstract] [Full Text] [Related]
32. Update on off label use of metformin for obesity.
El-Arabey AA
Prim Care Diabetes; 2018 Jun; 12(3):284-285. PubMed ID: 29525383
[No Abstract] [Full Text] [Related]
33. Single-composition extended-release metformin hydrochloride. A viewpoint by Vivian Fonseca.
Fonseca V
Treat Endocrinol; 2004; 3(5):333-4. PubMed ID: 15330684
[No Abstract] [Full Text] [Related]
34. Single-composition extended-release metformin hydrochloride. A viewpoint by David Bell.
Bell D
Treat Endocrinol; 2004; 3(5):333. PubMed ID: 15330683
[No Abstract] [Full Text] [Related]
35. Metformin and prognosis of critical illness: a question of timing?
Christiansen CF
Crit Care; 2013; 17(6):471. PubMed ID: 25320755
[No Abstract] [Full Text] [Related]
36. Weight matters. How new antiobesity drugs can be part of diabetes management.
Tsai A
Diabetes Forecast; 2015; 68(1):50-5. PubMed ID: 25647938
[No Abstract] [Full Text] [Related]
37. Glumetza: once-a-day dosing for management of type 2 diabetes.
Laustsen G
Nurse Pract; 2006 May; 31(5):50-1. PubMed ID: 16680087
[No Abstract] [Full Text] [Related]
38. Metformin in obese teenagers does not improve glycaemic control, study finds.
Wise J
BMJ; 2015 Dec; 351():h6430. PubMed ID: 26631217
[No Abstract] [Full Text] [Related]
39. Targeting the CNS to treat type 2 diabetes.
Sandoval DA; Obici S; Seeley RJ
Nat Rev Drug Discov; 2009 May; 8(5):386-98. PubMed ID: 19404312
[TBL] [Abstract][Full Text] [Related]
40. Metformin improves survival in intensive care unit patients, but why?
Riksen NP; Rongen GA; Pickkers P
Crit Care; 2013 Dec; 17(6):471. PubMed ID: 24330731
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
